Delivery Order SPE2DB22D2005-SPE2DB25FJQF7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,053.12 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 on July 28, 2025, with completion expected by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,316.42 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg tablets (100 count) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100s, with a ceiling value of $4,627.63 and an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets (100 count) on September 4, 2025, with a ceiling value of $1,034.62 and completion date of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100, with a ceiling value of $1,687.28. This firm fixed price delivery order, which represents a non-set-aside competitive award, is expected to be completed by August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,080.55 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of dextroamphetamine-amphetamine 15 mg tablets in quantities of 100 units, with a contract value of $2,381.06 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a standard pharmaceutical procurement through the federal medical supply chain with no set-aside designation. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 tablets. This contract is a firm fixed price delivery order with a ceiling value of $1,436.91 and an ultimate completion date of September 3, 2025. The award carries no set-aside designation and was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 units, with a ceiling value of $1,509.00. This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, was competitively awarded without set-aside restrictions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,377.89 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100-count units), with a completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQF7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100-count) with a ceiling value of $2,446.15. This firm fixed-price delivery order, which is not set-aside, represents a routine pharmaceutical procurement under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by July 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant prime contract position within the DLA's Medical Supply Chain, serving military healthcare systems and other federal agencies. The company's extensive portfolio demonstrates competency in delivering diverse pharmaceutical products, including controlled substances, specialty medications, vaccines, and medical devices across multiple therapeutic domains. As the child delivery order under the larger SPE2DX vehicle, this contract exemplifies the company's critical role in supporting federal medical procurement requirements through competitive, firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/23/25 |